IP Library Granted Patent US 9,642,923
Granted Patent B2
US 9,642,923 · App. 14/188,634 · Granted May 9, 2017

Engineered particles with polarization contrast and alignment control for enhanced imaging

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,642,923
App. No.
14/188,634
Granted
May 9, 2017
Kind
B2
Abstract

An engineered particle for detecting analytes in an environment includes an electromagnetic receiver that is configured to preferentially receive electromagnetic radiation of a specified polarization relative to the orientation of the electromagnetic receiver. The engineered particle additionally includes an energy emitter coupled to the electromagnetic receiver such that a portion of electromagnetic energy received by the electromagnetic receiver is transferred to and emitted by the energy emitter. The engineered particles are functionalized to selectively interact with an analyte. The engineered particle can additionally be configured to align with a directed energy field in the environment. The selective reception of electromagnetic radiation of a specified polarization and/or alignment with a directed energy field can enable orientation tracking of individual engineered particles, imaging in high-noise environments, or other applications. A method for detecting properties of the analyte of interest by interacting with the engineered particle is also provided.

Claims (15)

1. A contrast agent comprising a plurality of engineered particles, wherein each engineered particle of the contrast agent comprises:

a bioreceptor, wherein the bioreceptor selectively interacts with an analyte;

at least one conductive nanorod, wherein the at least one conductive nanorod absorbs polarized electromagnetic radiation that is aligned with an axis of the at least one conductive nanorod more than polarized electromagnetic radiation that is not aligned with the axis of the at least one conductive nanorod, wherein the conductive nanorod transduces a portion of electromagnetic energy received by the at least one conductive nanorod into a surface plasmon resonance, wherein the surface plasmon resonance generates a time-varying electric field around the conductive nanorod; and

at least one light emitter, wherein the at least one light emitter is located within the time-varying electric field that is generated around the conductive nanorod when the conductive nanorod transduces a portion of received electromagnetic energy into a surface plasmon resonance, and wherein the at least one light emitter transduces a time-varying electromagnetic field to which it is exposed into emitted light energy.

2. The contrast agent of claim 1 , wherein the conductive nanorod is attached to a first region of the bioreceptor and the light emitter is attached to a second region of the bioreceptor, and wherein the bioreceptor undergoes a conformational change in response to interacting with the analyte such that a distance between the first region of the bioreceptor and the second region of the bioreceptor is related to whether the bioreceptor is interacting with the analyte.

3. The contrast agent of claim 1 , wherein the at least one light emitter comprises a fluorophore.

4. The contrast agent of claim 1 , wherein the at least one light emitter comprises a quantum dot.

5. The contrast agent of claim 1 , wherein the conductive nanorod comprises superparamagnetic iron oxide coated in gold.

6. The contrast agent of claim 1 , wherein each engineered particle of the contrast agent further comprises a particle of superparamagnetic iron oxide, wherein the particle of superparamagnetic iron oxide experiences a torque when exposed to a magnetic field.

7. The contrast agent of claim 1 , wherein the bioreceptor and the light emitter are disposed on a surface of the conductive nanorod.

8. The contrast agent of claim 1 , wherein the bioreceptor comprises a protein, and wherein the light emitter comprises a fluorescent moiety of the protein.

9. The contrast agent of claim 8 , wherein the bioreceptor comprises a single recombinant protein.

10. The contrast agent of claim 1 , wherein the light emitter comprises a Raman dye.

11. The contrast agent of claim 1 , wherein the bioreceptor comprises an antibody.

12. The contrast agent of claim 1 , wherein the bioreceptor comprises an aptamer.

Assignments (6)
CHANGE OF ADDRESS Recorded Nov 19, 2024
From: VERILY LIFE SCIENCES LLC
To: VERILY LIFE SCIENCES LLC
Reel/Frame 069390/0656 →
CORRECTIVE ASSIGNMENT TO CORRECT THE THE REMOVAL OF THE INCORRECTLY RECORDED APPLICATION NUMBERS 14/149802 AND 15/419313 PREVIOUSLY RECORDED AT REEL: 44144 FRAME: 1. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Mar 4, 2024
From: GOOGLE INC.
To: GOOGLE LLC
Reel/Frame 068092/0502 →
CHANGE OF NAME Recorded Oct 6, 2017
From: GOOGLE INC.
To: GOOGLE LLC
Reel/Frame 044144/0001 →
CHANGE OF NAME Recorded Dec 17, 2015
From: GOOGLE LIFE SCIENCES LLC
To: VERILY LIFE SCIENCES LLC
Reel/Frame 037317/0139 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2015
From: GOOGLE INC.
To: GOOGLE LIFE SCIENCES LLC
Reel/Frame 037288/0768 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2014
From: HOMYK, ANDREW; ACOSTA, VICTOR MARCEL; BAJAJ, VIKRAM SINGH
To: GOOGLE INC.
Reel/Frame 032511/0887 →